The Evaluation of the Safety of a New Drug for Benign Prostatic Hyperplasia Used for 9 Months

Completed · Phase 3

Conditions studied: Benign Prostatic Hyperplasia

In brief

A new drug for benign prostatic hyperplasia is used for 9 months to determine its long-term safety.

Key facts

Study ID

NCT00224133

Run by

Watson Pharmaceuticals

People needed

661

Starts

2005-09-01

Expected to finish

2007-04-01

Last updated by the study team

2010-04-27

Who can join

Age: 50 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Males in good general health and at least 50 years of age, who have completed SI04009 or SI04010.

You may not qualify if…

• Medical conditions that would confound the efficacy evaluation.
• Medical conditions in which it would be unsafe to use an alpha-blocker.
• The use of concomitant drugs that would confound the efficacy evaluation.
• The use of concomitant drugs that would be unsafe with this alpha-blocker.

Where it is running

• Study site — Huntsville, Alabama, United States
• Study site — Tucson, Arizona, United States
• Study site — Anaheim, California, United States
• Study site — Carmichael, California, United States
• Study site — Culver City, California, United States
• Study site — Fresno, California, United States
• Study site — Irvine, California, United States
• Study site — La Jolla, California, United States
• Study site — Laguna Woods, California, United States
• Study site — Long Beach, California, United States
• Study site — Newport Beach, California, United States
• Study site — San Bernardino, California, United States
• Study site — San Diego, California, United States
• Study site — Tarzana, California, United States
• Study site — Torrance, California, United States
• Study site — Aurora, Colorado, United States
• Study site — Wheat Ridge, Colorado, United States
• Study site — Waterbury, Connecticut, United States
• Study site — Aventura, Florida, United States
• Study site — Clearwater, Florida, United States
• Study site — Coral Gables, Florida, United States
• Study site — New Port Richey, Florida, United States
• Study site — Ocala, Florida, United States
• Study site — Orlando, Florida, United States
• Study site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.